Summary
Catecholamines have an important endocrine and neuroendocrine role in mediating a variety of autonomic functions. One consequence of normal aging, in particular in the cardiovascular system, is a decline in β-adrenergic function associated with an alteration in responsiveness to β-adrenergic therapy. The intrinsic ability for muscle contractility or relaxation is maintained with age and there appears to be an alteration in the process linking the receptor with the contractile or relaxation mechanisms.
In rats, β-adrenergic receptor density decreases with age in adipose tissues and most brain areas, is unchanged in lymphocytes, heart and lung, and increases in the liver. In humans, there are no receptor changes with age in either lymphocytes or brain. In contrast, the number of high-affinity receptors (or coupled receptors) decreases with age in most tissues. In addition, there is a decrease in membrane adenylate cyclase activity or cellular production of cyclic adenosine monophosphate (adenosine 3′,5′-cyclic phosphate; cAMP).
Plasma noradrenaline (norepinephrine) concentration increases with age. The reduced receptor number in some tissues (down-regulation), the reduced high-affinity receptors and the reduced hormone-stimulated adenylate cyclase activity with age suggests receptor desensitisation to increased plasma noradrenaline concentration. The inability of older animals to desensitise to β-adrenergic agonists further supports this hypothesis. However, there is an additional post-receptor reduction in catalytic unit activity with age independent of desensitisation.
Medications directed at the β-adrenergic system are commonly used in the elderly. Many of the data on the impact of age on clinical responses are conflicting or unavailable. Concomitant disease, functional status, nutritional state and polypharmacy may play an even greater role than age. However, the available data can be used to guide the selection of therapy, anticipate side effects, and predict potential interactions with other medications and diseases.
Similar content being viewed by others
References
Aberg G, Adler G. The effect of age on beta-adrenoceptor activity in tracheal smooth muscle. British Journal of Pharmacology 47: 181–182, 1973
Abrass IB. Catecholamine levels and vascular responsiveness in aging. In Horan MJ, et al. (Eds) Blood pressure regulation and aging, an NIH Symposium, pp. 123–130, Biomedical Information Corporation, New York, 1986
Abrass IB, Davis JL, Scarpace PJ. Isoproterenol responsiveness and myocardial beta adrenergic receptors in young and old rats. Journal of Gerontology 37: 156–160, 1982
Abrass IB, Scarpace PJ. Human lymphocyte beta-adrenergic receptors are unaltered with age. Journal of Gerontology 26: 298–301, 1981
Abrass IB, Scarpace PJ. Catalytic unit of adenylate cyclase: reduce activity in aged-human lymphocytes. Journal of Clinical Endocrinology and Metabolism 55: 1026–1028, 1982
Applegate WB. Hypertension in elderly patients. Annals of Internal Medicine 110: 901–915, 1989
Avorn J, Everitt D, Weiss S. Increased antidepressant use in patients prescribed beta-blockers. Journal of the American Medical Association 255: 357, 1986
Bertel O, Buhler FR, Kiowski W, Lutold BE. Decreased beta-adrenoceptor responsiveness as related to age, blood pressure and plasma catecholamines in patients with essential hypertension. Hypertension 2: 130–138, 1980
Blumberg JB. A discussion of drug metabolism and actions in the aged. Drug-Nutrient Interactions 4: 99–106, 1985
Brodde OE. Endogenous and exogenous regulation of human α- and β-adrenergic receptors. Journal of Receptor Research 3: 151–162, 1983
Buhler FR, Hulthen UL, Kiowski W, Bolly P. Beta-blockers and calcium antagonists: cornerstones of antihypertensive therapy in the 1980s. Drugs 25(Suppl. 2): 50, 1983
Cimino M, Vantini G, Algeri S, Curatola G, Pezzoli C, et al. Age-related modification of dopaminergic and beta-adrenergic receptor system: restoration to normal activity by modifying membrane fluidity with S-adenosylmethionine. Life Sciences 34: 2029–2039, 1984
Coakes RL, Mackei IA, Seal DV. Effects of long-term treatment with timolol on lacrimal gland function. British Journal of Ophthalmology 65: 603–605, 1981
Conway J. Effect of age on the response to propranolol. International Journal of Clinical Pharmacology and Therapeutic Toxicology 4: 148–150, 1970
Covinsky JO. New therapeutic modalities for the treatment of elderly patients with heart disease. American Journal of Medicine 82(Suppl. IB): 41–46, 1987
Cydulka R, Davison R, Grammer L, Parker M, Mathews J. The use of epinephrine in the treatment of older adult asthmatics. Annals of Emergency Medicine 17: 322–326, 1988
Davis PB, Byard PJ. Beta-adrenergic response and airway reactivity in healthy adults. Mechanisms of Ageing and Development 54: 29–42, 1990
Dax EM, Partilla JS, Pineyro MA, Gregerman RI. β-Adrenergic receptors, glucagon receptors, and their relationship to adenylate cyclase in rat liver during aging. Endocrinology 120: 1534–1541, 1987
DeBlasi A, Cotecchia S, Mennini T. Selective changes of receptor binding in brain regions of aged rats. Life Sciences 31: 335–340, 1982
DeBlasi A, Lipartiti M, Algeri S, Sacchetti G, Constantini C, et al. Stress induced desensitization of lymphocyte β-adrenoceptors in young and aged rats. Pharmacology of Biochemical Behavior 24: 991–998, 1986
Dimenas ES, Dahlof CG, Heibel B, Moore RG, Olofsson BK, et al. Subjective symptoms and pharmacokinetics/dynamics of metoprolol CR in elderly subjects: a comparison with atenolol. European Journal of Clinical Pharmacology 38: 571–578, 1990
Doyle V, O’Malley K, Kelly JG. Human lymphocyte beta-adrenoceptor density in relation to age and hypertension. Journal of Cardiovascular Pharmacology 4: 738–740, 1982
Duckies SP, Hurlbert JS. Effect of age on beta adrenergic relaxation of the rat jugular vein. Journal of Pharmacology and Experimental Therapeutics 236: 71–74, 1986
Editorial. Betaxolol for hypertension. Medical Letters on Drugs and Therapeutics 32: 62, 1990
Everitt DE, Avorn J. Systemic effects of medications used to treat glaucoma. Annals of Internal Medicine 112: 120–125, 1990
Fan T-HM, Baneijee SP. Age-related reduction of beta-adrenoceptor sensitivity in rat heart occurs by multiple mechanisms. Gerontology 31: 373–380, 1985
Feely J, Stevenson IH. The influence of ageing on propranolol concentration, binding, and efficacy in hyperthyroid patients. Journal of Clinical and Experimental Gerontology 1: 173–184, 1979
Feldman RD, Limbird LE, Nadeau J, Robertson D, Wood AJJ. Alterations in leukocyte b-receptor affinity with aging: a potential explanation for altered β-adrenergic sensitivity in the elderly. New England Journal of Medicine 310: 815–819, 1984
Fleisch JH, Maline HM, Brodie BB. Beta-receptor activity in aorta. Circulation Research 26: 151–162, 1970
France LA, Green FL, Snow HM. The effects of age, sex, and treatment with xamoterol on exercise capacity in patients with heart failure. British Journal of Clinical Pharmacology 28: 75S–77S, 1989
Friedman E, Cooper T, Yocca F. The effect of imipramine treatment on brain serotonin receptors and β-adrenoceptors and on pineal β-adrenergic function in adult and aged rats. European Journal of Pharmacology 123: 351–356, 1986
Gengo FM, Fagan SC, de Padova A, Miller JK, Kinkel PR. The effect of beta-blockers on mental performance on older hypertensive patients. Archives of Internal Medicine 148: 779–784, 1988
Giudicelli V, Pecquery R. Beta adrenergic receptors and catecholamine sensitive adenylate cyclase in rat fat cell membranes: influence of growth, cell size and aging. European Journal of Biochemistry 90: 413–419, 1978
Greenberg LH, Brunswick D, Weiss B. The effect of age on the recovery of beta-adrenergic receptors in rat brain following desmethylimipramine-induced subsensitivity. Brain Research 328: 81–88, 1979
Greenberg LH, Weiss B. Beta-adrenergic receptors in aged rat brain: reduced number and capacity of pineal gland to develop supersensitivity. Science 201: 61–62, 1978
Greenblatt DJ, Koch-Weser J. Adverse reactions to propranolol in hospitalized medical patients: a report from the Boston Collaborative Drug Surveillance Program. American Heart Journal 86: 478–484, 1973
Guarnieri T, Filburn CR, Zitnik G, Roth GS, Lakatta EG. Contractile and biochemical correlates of β-adrenergic stimulation of the aged heart. American Journal of Physiology 239: H501–H508, 1980
Halper JP, Mann JJ, Weksler ME, Bilezikian JP, Sweeney JA, et al. Beta adrenergic receptors and cyclic AMP levels in intact human lymphocytes: effect of age and gender. Life Sciences 35: 855–863, 1984
Hayes LP, Stewart CJ, Kim I, Mohr JA. Timolol side effects and inadvertent overdosing. Journal of the American Geriatric Society 37: 261–262, 1989
Hess GD, Roth GS. Receptors and aging. In Johnson (Ed.) Aging and cell function, pp. 149–185, Plenum Press, New York, 1984
Johnson GL, Dhanasekaran N. The G-protein family and their interaction with receptors. Endocrine Reviews 10: 317–331, 1989
Kalaria RN, Andorn AC, Tabaton M, Whitehouse PJ, Harik SI, et al. Adrenergic receptors in aging and Alzheimer’s disease: increased β2-receptors in prefrontal cortex and hippocampus. Journal of Neurochemistry 53: 1772–1781, 1989
Kaplan NM. Critical comments on recent literature: age and the response to antihypertensive drugs. American Journal of Hypertension 2: 213–215, 1989
Kirkendall WM. Treatment of hypertension in the elderly. American Journal of Cardiology 57: 63C–68C, 1986
Klein C, Hiatt WR, Gerber JG, Nies AS. The balance between vascular alpha- and beta-adrenoceptors is not changed in the elderly. Clinical Pharmacology and Therapeutics 42: 260–264, 1987
Kohno A, Seeman P, Cinader B. Age-related changes of beta-adrenoceptors in aging inbred mice. Journal of Gerontology 41: 439–444, 1986
Kraft CA, Castleden CM. The effect of aging on beta-adrenoceptor-stimulated cAMP formation in human lymphocytes. Clinical Science 60: 587–589, 1981
Krall JF, Connelly M, Weisbart R, Tuck ML. Age-related elevation of plasma catecholamine concentration and reduced responsiveness of lymphocyte adenylate cyclase. Journal of Clinical Endocrinology and Metabolism 52: 863–867, 1981
Kusiak JW, Pitha J. Decreased response with age of the cardiac catecholamine sensitive adenylate cyclase system. Life Sciences 33: 1679–1686, 1983
Lakatta EG, Gerstenblith G, Angell CS, Shock NW, Weisfeldt ML. Diminished inotropic response of aged myocardium to catecholamines. Circulation Research 36: 262–269, 1975
Landmann R, Bittiger H, Buhler FR. High affinity beta2-adrenergic receptors in mononuclear leukocytes: similar density in young and old normal subjects. Life Sciences 29: 1761–1771, 1981
Lipworth BJ, Tragaskis BF, McDevitt DG. Beta-adrenoceptor responses to inhaled salbutamol in the elderly. British Journal of Clinical Pharmacology 28: 725–729, 1989
Mader SL. Aging and postural hypotension: an update. Journal of the American Geriatric Society 37: 129–137, 1989
Mader SL, Davis PB. Effect of age on acute regulation of beta-adrenergic responses in mononuclear leukocytes. Journal of Gerontology 44: M168–M173, 1989
Maggi A, Schmidt MJ, Ghetti B, Enna SJ. Effects of aging on neurotransmitter receptor binding in rat and human brain. Life Sciences 24: 367–374, 1979
Miller JA, Zahniser NR. Quantitative autoradiographic analysis of 125I-pindolol binding in Fischer 344 rat brain: changes in β-adrenergic receptor density with aging. Neurobiology of Aging 9: s267–272, 1988
Misra CH, Shelat HS, Smith RC. Effect of age on adrenergic and dopaminergic receptor binding in rat brain. Life Sciences 27: 521–526, 1980
Montamat SC, Cusak BJ, Vestal RE. Management of drug therapy in the elderly. New England Journal of Medicine 321: 303–309, 1989
Montamat SC, Davies AO. Physiological response to isoproterenol and coupling of beta-adrenergic receptors in young and elderly human subjects. Journal of Gerontology 44: M100–M105, 1989
Motulsky HJ, Insel PA. Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations. New England Journal of Medicine 307: 18–29, 1982
Narayanan N, Derby JA. Alterations in the properties of beta-adrenergic receptors of myocardial membranes in aging: impairments in agonist-receptor interactions and guanine nucleotide regulation accompany diminished catecholamine-responsiveness of adenylate cyclase. Mechanisms of Ageing and Development 19: 127–139, 1982
O’Connor SW, Scarpace PJ, Abrass IB. Age-associated decrease of adenylate cyclase activity in rat myocardium. Mechanisms of Ageing and Development 16: 91–95, 1981
O’Connor SW, Scarpace PJ, Abrass IB. Age-associated decrease in the catalytic unit activity of rat myocardial adenylate cyclase. Mechanisms of Ageing and Development 21: 357–363, 1983
O’Connor SW, Scarpace PJ, Abrass IB. The effect of age and cholesterol on the rat lung beta-adrenergic system. Biochimica et Biophysica Acta 778: 497–502, 1984
O’Hara N, Daul AE, Fesel R, Siekmann U, Brodde OE. Different mechanisms underlying reduced β2-adrenoceptor responsiveness in lymphocytes from neonates and old subjects. Mechanisms of Ageing and Development 31: 115–122, 1985
Pan HY-M, Hoffman BB, Pershe RA, Blaschke TR. Decline in beta adrenergic receptor-mediated vascular relaxation with aging in man. Journal of Pharmacology and Experimental Therapeutics 239: 802–807, 1986
Pitha J, Hughes BA, Kusiak JW, Dax EM, Baker SP. Regeneration of β-adrenergic receptors in senescent rats: a study using an irreversible binding antagonist. Proceedings of the National Academy of the Sciences USA 79: 4424–4427, 1982
Platt D. Pharmacotherapy and old age. Triangle (Sandoz Journal of Medical Science) 25: 43–52, 1986
Prakash UBS, Rosenow III EC. Pulmonary complications from ophthalmic preparations. Mayo Clinical Proceedings 65: 521–529, 1990
Raymond JR, Hnatowich M, Lefkowitz RJ, Caron MG. Adrenergic receptors: models for regulation of signal transduction processes. Hypertension 15: 119–131, 1990
Roberts J, Turner N. Age-related changes in autonomic function of catecholamines. In Rothstein (Ed.) Review of biological research in aging, vol. 3, pp. 257–298, Alan R. Liss, New York, 1987
Scarpace PJ. Decreased receptor activation with age: can it be explained by desensitization? Journal of the American Geriatric Society 36: 1067–1071, 1988
Scarpace PJ. Forskolin activation of adenylate cyclase in rat myocardium with age: effects of guanine nucleotide analogs. Mechanisms of Ageing and Development 52: 169–178, 1990
Scarpace PJ, Abrass IB. Thyroid hormone regulation of β-adrenergic receptor number in aging rats. Endocrinology 108: 1276–1278, 1981
Scarpace PJ, Abrass IB. Decreased beta-adrenergic agonist affinity and adenylate cyclase activity in senescent rat lung. Journal of Gerontology 38: 143–147, 1983
Scarpace PJ, Abrass IB. Beta-adrenergic agonist-mediated desensitization in senescent rats. Mechanisms of Ageing and Development 35: 255–264, 1986
Scarpace PJ, Baresi LA. Increased beta-adrenergic receptors in the light-density membrane fraction in lungs from senescent rats. Journal of Gerontology 43: B163–B167, 1988
Scarpace PJ, Mooradian AD, Morley JE. Age-associated decrease in beta-adrenergic receptors and adenylate cyclase activity in rat brown adipose tissue. Journal of Gerontology 43: B65–B70, 1988
Sibley DR, Lefkowitz RJ. Molecular mechanisms of receptor desensitization using the beta-adrenergic receptor-coupled adenylate cyclase system as a model. Nature 317: 124–129, 1985
Strader CD, Candelore MR, Hill WS, Dixon RAF, Sigal IS. A single amino acid substitution in the β-adrenergic receptor promotes partial agonist activity from antagonists. Journal of Biological Chemistry 264: 16470–16477, 1989
Stressman J, Eliakim R, Cahan C, Ebstein RP. Deterioration of beta-receptor-adenylate cyclase function in elderly, hospitalized patients. Journal of Gerontology 39: 667–672, 1984
Swift CG. Pharmacodynamics: changes in homeostatic mechanisms, receptor and target organ sensitivity in the elderly. British Medical Bulletin 46: 36–52, 1990
Tasch MD. The autonomic nervous system and geriatric anesthesia. International Anesthesiology Clinics 26: 143–151, 1988
Turner N, Bender J, Roberts J. Absence of age-related changes in the binding of the beta adrenergic antagonist 125I-iodohydroxybenzylpindolol in rat heart. Proceedings of the Society for Experimental Biology and Medicine 186: 118–122, 1987
Turner N, Houck WT, Boehm C, Roberts J. Cardiac adrenergic beta receptor binding characteristics with age following adrenal demedullation. British Journal of Pharmacology 99: 87–90, 1990a
Turner N, Houck WT, Roberts J. Upregulation of adrenergic beta receptor subtypes in the senescent rat heart. Mechanisms of Ageing and Development 49: 235–243, 1989
Turner N, Houck WT, Roberts J. Effect of age on upregulation of the cardiac adrenergic beta receptors. Journal of Gerontology 45: B48–B51, 1990b
Ullah MI, Newman GB, Sanders KB. Influence of age on response to ipratropium and salbutamol in asthma. Thorax 36: 523–529, 1981
Vanscheeuwijck P, Van de Velde E, Fraeyman N. Effect of aging on properties and function of β-adrenoceptors in rat lung. European Journal of Pharmacology 172: 373–380, 1989
Vestal RE, Wood AJJ, Shand DG. Reduced β-adrenoceptor sensitivity in the elderly. Clinical Pharmacology and Therapeutics 26: 181–186, 1979
Weiss B, Greenberg L, Cantor E. Age-related alterations in the development of adrenergic denervation supersensitivity. Federation Proceedings 38: 1915–1921, 1979
Weiss ER, Kelleher DJ, Woon CW, Soparkar S, Osawa S, et al. Receptor activation of G proteins. FASEB Journal 2: 2841–2848, 1988
Wikstrand J, Westergran G, Bergland G, Bracchetti D, Vancouter A, et al. Antihypertensive treatment with metoprolol or hydrochlorothiazide in patients aged 60-75 years. Journal of the American Medical Association 255: 1304–1310, 1986
Yin F, Spurgeon H, Green H, Lakatta E, Weisfeldt ML. Age associated decrease in heart rate response to isoproterenol in dogs. Mechanisms of Ageing and Development 10: 17–25, 1979
Zahniser NR, Bier-Laning CM, Gerber JG, Nies AS. Timolol-induced upregulation of polymorphonuclear leukocyte beta-2- adrenergic receptors in the elderly. Clinical Pharmacology and Therapeutics 45: 469–475, 1989
Zahniser NR, Parker DC, Bier-Laning CM, Miller JA, Gerber JG, et al. Comparison between the effects of aging on antagonist and agonist interactions with beta-adrenergic receptors on human mononuclear and polymorphonuclear leukocyte membranes. Journal of Gerontology 43: M151–M157, 1988
Acknowledgements
This work was supported by the Medical Research Service of the Department of Veterans Affairs (PJS and NT) and by US Public Health Service grant K08 AG 00387 (SLM). The authors appreciate the assistance of Linda Pritchett in the preparation of the manuscript.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Scarpace, P.J., Turner, N. & Mader, S.L. β-Adrenergic Function in Aging. Drugs & Aging 1, 116–129 (1991). https://doi.org/10.2165/00002512-199101020-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00002512-199101020-00004